These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy. Xia Y; Xiao M; Zhao M; Xu T; Guo M; Wang C; Li Y; Zhu B; Liu H Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110100. PubMed ID: 31753388 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured toxins for the selective destruction of drug-resistant human CXCR4 Serna N; Álamo P; Ramesh P; Vinokurova D; Sánchez-García L; Unzueta U; Gallardo A; Céspedes MV; Vázquez E; Villaverde A; Mangues R; Medema JP J Control Release; 2020 Apr; 320():96-104. PubMed ID: 31931052 [TBL] [Abstract][Full Text] [Related]
19. Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease. Vanderburgh JP; Kwakwa KA; Werfel TA; Merkel AR; Gupta MK; Johnson RW; Guelcher SA; Duvall CL; Rhoades JA J Control Release; 2019 Oct; 311-312():257-272. PubMed ID: 31494183 [TBL] [Abstract][Full Text] [Related]
20. Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug-Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release. Li Y; Lin J; Yang X; Li Y; Wu S; Huang Y; Ye S; Xie L; Dai L; Hou Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):17573-81. PubMed ID: 26234408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]